blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4019478

EP4019478 - BIOACTIVE CRYSTALLIZED GLASS CERAMIC COMPRISING WOLLASTONITE, HYDROXYAPATITE AND DIOPSIDE, AND USE THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  27.05.2022
Database last updated on 20.07.2024
FormerThe international publication has been made
Status updated on  26.02.2021
Most recent event   Tooltip28.03.2024Change - representative 
Applicant(s)For all designated states
CG Bio Co., Ltd.
244 Galmachi-ro
Jungwon-gu
Seongnam-si, Gyeonggi-do 13211 / KR
[2022/26]
Inventor(s)01 / KIM, Baek-Hyun
102ho, Na-dong, 37-1, Gongneung-ro 12-gil,
Jungnang-gu
Seoul 02031 / KR
02 / RYU, Hyun Seung
801ho, 408dong, 70, Neuti-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13611 / KR
03 / SEO, Jun Hyuk
1304ho, 6404dong, 215, Wiryejungang-ro
Hanam-si, Gyeonggi-do 13014 / KR
04 / SONG, Seok Beom
601ho, 110dong, 6, Hwangsong-ro, Jungwon-gu
Seongnam-si, Gyeonggi-do 13186 / KR
 [2022/26]
Representative(s)Müller Schupfner & Partner Patent- und Rechtsanwaltspartnerschaft mbB (Hamburg)
Schellerdamm 19
21079 Hamburg / DE
[N/P]
Former [2022/26]Müller Schupfner & Partner Patent- und Rechtsanwaltspartnerschaft mbB
Schellerdamm 19
21079 Hamburg / DE
Application number, filing date19941940.922.08.2019
[2022/26]
WO2019KR10665
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021033803
Date:25.02.2021
Language:KO
[2021/08]
Type: A1 Application with search report 
No.:EP4019478
Date:29.06.2022
Language:EN
[2022/26]
Search report(s)International search report - published on:KR25.02.2021
(Supplementary) European search report - dispatched on:EP02.05.2023
ClassificationIPC:C03C10/00, C03C4/00, A61L27/10, A61L27/12, A61F2/44, A61F2/30
[2022/26]
CPC:
C03C10/0054 (EP,US); A61L27/047 (US); A61L27/10 (EP,US);
A61L27/12 (US); A61L27/425 (US); A61L27/427 (US);
A61L27/50 (US); C03C3/064 (EP); C03C4/0007 (EP,US);
A61F2/4455 (EP); A61F2/447 (EP); A61F2002/30593 (EP);
A61F2002/3092 (EP); A61F2002/3093 (EP); A61F2002/30962 (EP);
A61F2002/30985 (EP); A61F2310/00179 (EP); A61F2310/00197 (EP);
A61F2310/00215 (EP); A61F2310/00263 (EP); A61F2310/00293 (EP);
A61F2310/00329 (EP); A61L2430/02 (EP); A61L2430/38 (US);
C03B32/02 (US); C03C2204/00 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/26]
TitleGerman:BIOAKTIVE KRISTALLISIERTE GLASKERAMIK MIT WOLLASTONIT, HYDROXYLAPATIT UND DIOPSID SOWIE DEREN VERWENDUNG[2022/26]
English:BIOACTIVE CRYSTALLIZED GLASS CERAMIC COMPRISING WOLLASTONITE, HYDROXYAPATITE AND DIOPSIDE, AND USE THEREOF[2022/26]
French:VITROCÉRAMIQUE CRISTALLISÉE BIOACTIVE COMPRENANT DE LA WOLLASTONITE, DE L'HYDROXYAPATITE ET DU DIOPSIDE, ET SON UTILISATION[2022/26]
Entry into regional phase20.01.2022Translation filed 
20.01.2022National basic fee paid 
20.01.2022Search fee paid 
20.01.2022Designation fee(s) paid 
20.01.2022Examination fee paid 
Examination procedure20.01.2022Examination requested  [2022/26]
01.12.2023Amendment by applicant (claims and/or description)
01.12.2023Date on which the examining division has become responsible
Fees paidRenewal fee
20.01.2022Renewal fee patent year 03
26.08.2022Renewal fee patent year 04
31.08.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2005079226  (GONDA YUKIKO [JP], et al) [X] 6-8,10,12* example -; claim -; table - *;
 [X]EP3225598  (BIOALPHA CORP [KR]) [X] 1-15 * paragraphs [0001] , [0006] - [0031]; figure -; example -; claim - *;
 [X]KR20180056370  (CG BIO CO LTD [KR]) [X] 6-12 * figure -; example -; claim - *
International search[Y]KR20090035649  (TAKIRON CO [JP]) [Y] 6-12 * See claims 1 and 16. *;
 [Y]KR20090037889  (IMP INNOVATIONS LTD [GB]) [Y] 4,5 * See claims 1 and 3. *;
 [Y]KR20140014354  (PURAC BIOCHEM BV [NL]) [Y] 14,15 * See paragraphs [0137] and [0153]. *;
 [XY]KR101724592B  (BIOALPHA CORPORATION) [X] 1-3,13 * See claims 1, 6, 8 and 9; and paragraph [0035]. * [Y] 4-12,14,15;
 [A]KR20180056370  (CG BIO CO LTD [KR]) [A] 1-15* See entire document. *
by applicant   - T. KOKUBO et al., Journal of Materials Science, (19850000), pages 2001 - 2004
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.